Research programme: viral budding inhibitors - Biotron
Alternative Names: BIT 009; Next-generation viroporin inhibitors - BiotronLatest Information Update: 28 Sep 2023
At a glance
- Originator Biotron
- Class Antivirals; Small molecules
- Mechanism of Action Viral protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical COVID 2019 infections
- Research Ebola virus infections; Hepatitis B; Influenza virus infections
- No development reported Dengue; Severe acute respiratory syndrome; Zika virus infection
Most Recent Events
- 28 Sep 2023 No recent reports of development identified for preclinical development in Severe acute respiratory syndrome in Australia
- 28 Sep 2023 No recent reports of development identified for preclinical development in Severe acute respiratory syndrome in USA
- 28 Sep 2023 No recent reports of development identified for research development in Dengue in Australia